Zawiejska, A.; Wróblewska-Seniuk, K.; Gutaj, P.; Kippen, J.; Gomulska, A.; Wender-Ozegowska, E.
Markers of Maternal Insulin Resistance and Lipid Ratios Measured in Early Pregnancy Are Related to Adverse Fetomaternal Outcomes in Women Treated for Hyperglycemia Detected in Early Pregnancy—Data from a Retrospective Cohort Study. J. Clin. Med. 2022, 11, 1777.
https://doi.org/10.3390/jcm11071777
AMA Style
Zawiejska A, Wróblewska-Seniuk K, Gutaj P, Kippen J, Gomulska A, Wender-Ozegowska E.
Markers of Maternal Insulin Resistance and Lipid Ratios Measured in Early Pregnancy Are Related to Adverse Fetomaternal Outcomes in Women Treated for Hyperglycemia Detected in Early Pregnancy—Data from a Retrospective Cohort Study. Journal of Clinical Medicine. 2022; 11(7):1777.
https://doi.org/10.3390/jcm11071777
Chicago/Turabian Style
Zawiejska, Agnieszka, Katarzyna Wróblewska-Seniuk, Paweł Gutaj, Joanna Kippen, Anna Gomulska, and Ewa Wender-Ozegowska.
2022. "Markers of Maternal Insulin Resistance and Lipid Ratios Measured in Early Pregnancy Are Related to Adverse Fetomaternal Outcomes in Women Treated for Hyperglycemia Detected in Early Pregnancy—Data from a Retrospective Cohort Study" Journal of Clinical Medicine 11, no. 7: 1777.
https://doi.org/10.3390/jcm11071777
APA Style
Zawiejska, A., Wróblewska-Seniuk, K., Gutaj, P., Kippen, J., Gomulska, A., & Wender-Ozegowska, E.
(2022). Markers of Maternal Insulin Resistance and Lipid Ratios Measured in Early Pregnancy Are Related to Adverse Fetomaternal Outcomes in Women Treated for Hyperglycemia Detected in Early Pregnancy—Data from a Retrospective Cohort Study. Journal of Clinical Medicine, 11(7), 1777.
https://doi.org/10.3390/jcm11071777
